TABLE 3.
Adult AD cohort (n = 31,164) | Adult control cohort (n = 93,492) | Incremental difference | P value | |
---|---|---|---|---|
Patients with absence eligibility, n (%) | 726 (2.3) | 2,407 (2.6) | −0.2% | 0.02 |
Patients with an absence claim, n (%) | 581 (80.0) | 1,817 (75.5) | 4.5% | 0.01 |
Indirect costs, mean (SD) | $6,323 ($4,226) | $6,037 ($4,681) | $286 | 0.14 |
Patients with short-term disability eligibility, n (%) | 4,936 (15.8) | 14,491 (15.4) | 0.4% | 0.07 |
Patients with a short-term disability claim, n (%) | 291 (5.9) | 672 (4.7) | 1.2% | < 0.001 |
Indirect costs, mean (SD) | $360 ($2,266) | $276 ($1,860) | $84 | 0.01 |
Patients with workers’ compensation eligibility, n (%) | 3,201 (10.3) | 9,766 (10.4) | −0.1% | 0.39 |
Patients with a workers’ compensation claim, n (%) | 26 (0.8) | 68 (0.7) | 0.1% | 0.5 |
Indirect costs, mean (SD) | $104 ($1,670) | $89 ($1,472) | $15 | 0.63 |
Note: Costs are in 2018 US dollars.
AD = atopic dermatitis.